State Drug Utilization Analyses
2025-Alabama Medicaid Prescriptions
$ 777,675,140
Per RX Cost: $162.69
Total Number of Prescriptions: 4,780,044
Total Medicaid Amount Reimbursed: $777,675,140
Total Amount Reimbursed: $735,937,491
Total Non-Medicaid Amount Reimbursed:
$ 41,737,648
% of Non-Medicaid Reimbursed: 5.4
Some Top RX Costs
Regeneron and Sanofi-DUPIXENT
Interleukin antagonist
$4,106 (7353 RXs) $30 Million
Abbvie-HUMIRA
Tumor necrosis factor (TNF) blocker
$10,539.91 (2740 RXs) $28 Milllion
Vertex Pharmaeuticals-TRIKAFTA
CFTR combination treatment (CF)
$26,546.10 (1058 RXs) $28 Million
Genentech-HEMLIBRA
Bispecific monoclonal antibody (IgG4)
Hemophilia A
$65,923.32 (110 RXs) $7 Million
2025-Arizona Medicaid Prescriptions $1,910,290,106
Per RX Cost: $143.04
Total Number of Prescriptions: 13,355,051
Total Medicaid Amount Reimbursed: $ 1,852,961,797
Total Amount Reimbursed: $1,910,290,106
Total Non-Medicaid Amount Reimbursed:
$57.3 Million
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors
$4,141(20,271RXs) $83.9 Million
Janssen Pharmaceuticals-INVEGA
Atypical antipsychotic
$2,749 (28,998 RXs) $79.7Million
Eli Lilly-TRULICITY
Glucagon-like peptide-1 (GLP-1)
$1,064 (70,568 RXs) $75.1 Million
2025-California Medicaid Prescriptions $18,258,985,562
Per RX Cost: $204.69
Total Number of Prescriptions: 89,202,583
Total Medicaid Amount Reimbursed: $18,258,985,562
Total Amount Reimbursed: $17,674,574,162
Total Non-Medicaid Amount Reimbursed: $584,411,400
% of Non-Medicaid Reimbursed: 3
Some Top Costs
Eli Lilly-ZEPBOUND
GIP and GLP-1 receptor agonist
$1,060.31 (701,827 RXs) $744.2 Million
Boehringer Ingelheim and Eli Lilly-JARDIANCE
SGLT2 inhibitor
$1,050.32 (508,274 RXs) $533.8 Million
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors (INSTIs)
$5,674.53 (87,398 RXs) $495.9 Million
2025-Connecticut Medicaid Prescriptions $2,000,880,362.93
Per RX Cost: $219.70
Total Number of Prescriptions: 9,107,268
Total Medicaid Amount Reimbursed:$1,934,191,820
Total Amount Reimbursed: $2,000,880,362
Total Non-Medicaid Amount Reimbursed: $66,688,542
% of Non-Medicaid Reimbursed: 1
Some Top Costs
Novo Nordisk-OZEMPIC
GLP-1 receptor agonist
$1,126.03 (102,533 RXs) $115.5 Mil
Abbvie-HUMIRA
TNF blocker
$12,216.73 (6,955 RXs) $85 Mil
Regeneron Pharmaceuticals-DUPIXENT
IL-4 receptor alpha antagonist
$4,421.76 (15,543 RXs) $68.7 Mil
2025-Delaware Medicaid Prescriptions
$255,577,672
Per RX Cost: $115.19
Total Number of Prescriptions: 2,218,800
Total Medicaid Amount Reimbursed:
$255,577,672
Total Amount Reimbursed: $244,350,431
Total Non-Medicaid Amount Reimbursed: $584,411,400
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors (INSTIs)
$4,112.04 (3,943 RXs) $16.2 Million
American Regent-VENOFER
hematinic or iron replacement product
$3,862.94 (3,385 RXs) $13.1 Million
AbbVie-HUMIRA
tumor necrosis factor (TNF) blocker
$7,828.32 (1,282 RXs) $10 Million
2025-Hawaii Medicaid Prescriptions $259,057,113
Per RX Cost: $145.88
Total Number of Prescriptions: 1,775,860
Total Medicaid Amount Reimbursed: $259,057,113
Total Amount Reimbursed: $259,057,113
Total Non-Medicaid Amount Reimbursed: 0
% of Non-Medicaid Reimbursed: 0
Some Top RX Costs
Novo Nordisk-OZEMPIC
GLP1 receptor agonist
$1,118.27 (21,712 RXs) $24.2 Million
Regeneron Pharmaceuticals-DUPIXENT
interleukin-4 (IL-4) receptor alpha antagonist
$3,711.63 (2906 RXs) $10.8 Million
AbbVie -SKYRIZI
interleukin-23 (IL-23) inhibitor
$20,158.89 (374 RXs) $7.6Million
2025-Idaho Medicaid Prescriptions
$593,445,771
Per RX Cost: $155.23
Total Number of Prescriptions: 3,823,067
Total Medicaid Amount Reimbursed:
$ 574,935,176
Total Amount Reimbursed: $593,445,771
Total Non-Medicaid Amount Reimbursed: $18,510,594
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
AbbVie-HUMIRA(CF)
TNF Blocker
$8,343.38 (3,644 RXs) $30. 4 Million
Novo Nordisk-OZEMPIC
GLP1 receptor agonist
$979.45 (27,727 RXs) $27.2 Million
AbbVie-VRAYLAR
atypical antipsychotic
$1,432.49 (16,072 RXs) $23 Million
2025-Iowa Medicaid Prescriptions $953,590,005
Per RX Cost: $129.46
Total Number of Prescriptions: 7,366,013
Total Medicaid Amount Reimbursed: $817,990,259
Total Amount Reimbursed: $ 953,590,005
Total Non-Medicaid Amount Reimbursed:
$ 135,599,746
% of Non-Medicaid Reimbursed: 14
Some Top RX Costs
AbbVie-VRAYLAR
atypical antipsychotic
$1,721.95 (46,748 RXs) $80.5 Million
AbbVie-HUMIRA(CF)
TNF Blocker
$8,899.92 (8,446 RXs) $75.2 Million
Vertex Pharmaceuticals-Trikafta
triple-combination therapy
$26,936.80 (2,622 RXs) $70.6 Million
2025-Kentucky Medicaid Prescriptions $2,746,010,073
Per RX Cost: $120.70
Total Number of Prescriptions: 26,300,290
Total Medicaid Amount Reimbursed: $2,716,482,347
Total Amount Reimbursed: $2,746,010,073
Total Non-Medicaid Amount Reimbursed:
$29,527,726
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
AbbVie-VRAYLAR
atypical antipsychotic
$1,399.50 (102,173 RXs) $143 Million
Indivior Inc.-SUBLOCADE
partial opioid agonist-antagonist t
$1,931.24 (31,423 RXs) $60.7 Million
AbbVie-HUMIRA
TNF Blocker
$7,866.55 (7,705 RXs) $60.6 Million
2025-Maine Medicaid Prescriptions $541,183,396
Per RX Cost: $90.37
Total Number of Prescriptions: 2,842,740
Total Medicaid Amount Reimbursed: $509,715,629
Total Amount Reimbursed: $ 541,183,396
Total Non-Medicaid Amount Reimbursed:
$ 31,467,767
% of Non-Medicaid Reimbursed: 6
Some Top RX Costs
Indivior Inc.-SUBOXONE
Partial Opioid Agonist/Opioid Antagonist combination
$258.67 (94,267 RXs) $24.4 Million
AbbVie-HUMIRA
TNF Blocker
$8,128.06 (2,738 RXs) $22.3 Million
Takeda Pharmaceutical-VYVANSE
Central Nervous System (CNS) Stimulant
$342.84 (64,539 RXs) $22.1 Million
2025-Massachusetts Medicaid Prescriptions $2,524,205,729
Per RX Cost: $179.72
Total Number of Prescriptions: 14,045,490
Total Medicaid Amount Reimbursed: $2,415,894,168
Total Amount Reimbursed: $ 2,524,205,729
Total Non-Medicaid Amount Reimbursed: $108,311,560
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Eli Lilly-ZEPBOUND
GIP and GLP-1
$1,036.49 (204,267 RXs) $211.7 Million
AbbVie-HUMIRA
(TNF) blocker
$9,379.58 (10,993 RXs) $103.1 Million
Sanofi and Regeneron-DUPIXENT
inhibits IL-4 and IL-13 signaling
$1,426.19 (21,432 RXs) $82.7 Million
2025-Minnesota Medicaid Prescriptions
$1,462,939,874
Per RX Cost: $131.53
Total Number of Prescriptions: 11,122,166
Total Medicaid Amount Reimbursed:
$ 1,442,858,302
Total Amount Reimbursed: $1,462,939,874
Total Non-Medicaid Amount Reimbursed: $ 20,081,571
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Novo Nordisk-WEGOVY
GLP-1 receptor agonist
$1,305.12 (83,044 RXs) $108. 3 Million
AbbVie-Humira
TNF blocker
$8,841.27 (7,965 RXs) $70.4 Million
Novo Nordisk-Ozempic
GLP-1 receptor agonist
$976.58 (70,626) $69 Million
2025-Missouri Medicaid Prescriptions
$2,042,291,492
Per RX Cost: $128.73
Total Number of Prescriptions:15,864,400
Total Medicaid Amount Reimbursed:
$ 1,991,704,479
Total Amount Reimbursed: $ 2,042,291,492
Total Non-Medicaid Amount Reimbursed:
$ 50,587,012
% of Non-Medicaid Reimbursed: 2
Some Top RX Costs
Eli Lilly -ZEPBOUND
Incretin Mimetics / GIP and GLP-1 Rec/Agonist
$1,059.04 (125,397RXs) $132.8 Mil
AbbVie-HUMIRA
TNF blocker
$9,272.31( 9,853 RXs) $9.4 Mil
Gilead Sciences-BIKTARVY
Antiviral/Antiretroviral agent,
$4,000.23 (20,539 RXs) $82.2 Mil
2025-Nebraska Medicaid Prescriptions
$482,293,377
Per RX Cost: $126.61
Total Number of Prescriptions: 3,809,237
Total Medicaid Amount Reimbursed: $460,236,185
Total Amount Reimbursed: $ $482,293,377
Total Non-Medicaid Amount Reimbursed: $22,057,191
% of Non-Medicaid Reimbursed: 5
Some Top RX Costs
AbbVie-HUMIRA
tumor necrosis factor
$8,622.68 (2,450 RXs) $21.1 Mil
Sanofi & Regeneron-DUPIXENT
immunotherapy
$4,032.70 (5,236 RXs) $21.1 Mil
AbbVie-VRAYLAR
atypical antipsychotic
$1,459.07 (9,668 RXs) $14.1 Mil
2025-New Hampshire Medicaid Prescriptions $261,963,279
Per RX Cost: $133.83
Total Number of Prescriptions: 1,957,493
Total Medicaid Amount Reimbursed: $259,870,816
Total Amount Reimbursed: $ 261,963,279
Total Non-Medicaid Amount Reimbursed: $2,092,463
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Novo Nordisk-WEGOVY
GLP-1 receptor agonists
$1,261.90 (12,703 RXs) $16 Mil
Vertex Pharmaceuticals-TRIKAFTA
CFTR modulator
$24,524.71 (567 RXs) $13.9 Mil
AbbVie-HUMIRA
TNF blocker
$9,278.92 (1,276 RXs) $11.8 Mil
2025-New Mexico Medicaid Prescriptions $671,655,321
Per RX Cost: $127.95
Total Number of Prescriptions: 5,249,441
Total Medicaid Amount Reimbursed: $667,826,229
Total Amount Reimbursed: $ 671,655,321
Total Non-Medicaid Amount Reimbursed: $3,829,092
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Novo Nordisk-OZEMPIC
(GLP-1) receptor agonist
$990.26 (39,128 RXs) $38.7 Mil
AbbVie-MAVYRET
Antiviral
$13,149.05 (1,124 RXs) $14.8 Mil
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$3,924.64 (4,440 RXs) $17.4 Mil
2025-North Carolina Medicaid Prescriptions $4,603,598,330
Per RX Cost: $210.24
Total Number of Prescriptions: 21,897,125
Total Medicaid Amount Reimbursed: $4,146,432,328
Total Amount Reimbursed: $ 4,603,598,330
Total Non-Medicaid Amount Reimbursed:
$ 457,166,002
% of Non-Medicaid Reimbursed: 10
Some Top RX Costs
Novo Nordisk-WEGOVY
GLP-1 receptor agonist
$1349.7 (203,038 RXs) $274 Mil
Abbvie -HUMIRA
(TNF) blocker
$10,652.42 (17,400 RXs) $185.4 Mil
Novo Nordisk-OZEMPIC
(GLP-1) receptor agonist
$1,118.95 (156523 RXs) $175 Mil
2025-Ohio Medicaid Prescriptions $4,608,959,401
Per RX Cost: $128.84
Total Number of Prescriptions: 35,772,840
Total Medicaid Amount Reimbursed: $4,535,937,258
Total Amount Reimbursed: $ 4,608,959,401
Total Non-Medicaid Amount Reimbursed: $73,022,143
% of Non-Medicaid Reimbursed: 2
Some Top RX Costs
Eli Lilly -TRULICITY
GLP-1 receptor agonist
$953.47 (343,775 RXs) $328 Mil
Abbvie-HUMIRA
TNF blocker
$9,210.47 (18,315 RXs) $168.7 Mil
AbbVie and Gedeon Richter-VRAYLAR
Atypical antipsychotic
$1,403.09 (101,813 RXs) $142.8 Mil
2025-Oregon Medicaid Prescriptions $967,085,498
Per RX Cost: $90.33
Total Number of Prescriptions: 10,706,034
Total Medicaid Amount Reimbursed: $925,391,749
Total Amount Reimbursed: $ 967,085,498
Total Non-Medicaid Amount Reimbursed: $41,693,748
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Gilead Sciences-BIKTARVY
antiretroviral
$4,352.01 (7,468 RXs) $32.5 Mil
AbbVie and Gedeon Richter-VRAYLAR
atypical antipsychotic
$1,421.05 (16,971 RXs) $24.1 Mil
Eli Lilly-TRULICITY
GLP-1 receptor agonist
$983.31 (23,685 RXs) $23.3 Mil
2025-Rohde Island Medicaid Prescriptions $306,594,647
Per RX Cost: $92.12
Total Number of Prescriptions: 3,328,218
Total Medicaid Amount Reimbursed: $306,214,799
Total Amount Reimbursed: $306,594,647.84
Total Non-Medicaid Amount Reimbursed $379,848
% of Non-Medicaid Reimbursed: 0
Some Top RX Costs
Novo Nordisk-OZEMPIC
GLP-1 receptor agonist
$978.20 (21,489 RXs) $21Mil
Gilead Sciences-BIKTARVY
antiretroviral
$4,136.48 (4,087 RXs) $16.9 Mil
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$3,935.26 (3,593 RXs) $14.1 Mil
2025-South Dakota Medicaid Prescriptions $283,268,775.64
Per RX Cost: $212.91
Total Number of Prescriptions: 1,330,450
Total Medicaid Amount Reimbursed: $ 279,857,156
Total Amount Reimbursed: $ 279,857,156
Total Non-Medicaid Amount Reimbursed $3,411,618
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$4,129.10 (2,595 RXs) $10.7 Mil
Janssen Pharmaceuticals-INVEGA
Atypical Antipsychotic
$3,304.45 (2,447 RXs) $8.1 Mil
Genentech -OCREVUS 30
CD20-directed cytolytic monoclonal antibody
$54,801.50 (135 RXs) $7.4 Mil
2025-Texas Medicaid Prescriptions $3,682,911,404.73
Per RX Cost: $139.90
Total Number of Prescriptions: 26,325,752
Total Medicaid Amount Reimbursed: $3,574,459,273
Total Amount Reimbursed: $3,682,911,404
Total Non-Medicaid Amount Reimbursed $108,452,131
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Janssen Pharmaceuticals-INVEGA
Atypical Antipsychotic
$3,594.47 (31,768 RXs) $114.2 Mil
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$3,977.84 (24,140 RXs) $96Mil
Vertex Pharmaeuticals-TRIKAFTA
CFTR combination treatment
$26,872.19 (3,420 RXs) $92 Mil
2025-Vermont Medicaid Prescriptions $170,238,570.15
Per RX Cost: $119.39
Total Number of Prescriptions: 1425,907
Total Medicaid Amount Reimbursed: $169,509,742
Total Amount Reimbursed: $170,238,570
Total Non-Medicaid Amount Reimbursed $728,827
% of Non-Medicaid Reimbursed: 0
Some Top RX Costs
Indivior Inc.-SUBOXONE
Partial Opioid Agonist/Opioid Antagonist
$205.11 (66,908 RXs) $13.7 Mil
AbbVie-HUMIRA
TNF Blocker
$7,643.41 (1,079 RXs) $8.2 Mil
Eli Lilly -TRULICITY
GLP-1 receptor agonist
$1,064.65 (5,744 RXs) $6.1 Mil
2025-Washington Medicaid Prescriptions $1,935,357,900.32
Per RX Cost: $144.11
Total Number of Prescriptions:13,429,866
Total Medicaid Amount Reimbursed: $1,876,997,773
Total Amount Reimbursed: $1,935,357,900
Total Non-Medicaid Amount Reimbursed $58,360,126
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Boehringer Ingelheim and Eli Lilly-JARDIANCE
SGLT2 inhibitor
$1,024.47 (80,350 RXs) $82.3 Mil
Regeneron Pharmaceuticals-DUPIXENT
interleukin-4 (IL-4) receptor alpha antagonist
$4,053.75 (15,145 RXs) $61.4 Mil
AbbVie-HUMIRA
TNF Blocker
$7,926.19 (6,945 RXs) $55 Mil
2025-Wisconsin Medicaid Prescriptions $2,161,655,244.49
Per RX Cost: $175.52
Total Number of Prescriptions: 12,316,053
Total Medicaid Amount Reimbursed: $2,098,147,016
Total Amount Reimbursed: $2,161,655,244
Total Non-Medicaid Amount Reimbursed: $63,508,228
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Abbvie -HUMIRA
TNF blocker
$9,016.99 (16,489 RXs) $148.7 Mil
Eli Lilly-ZEPBOUND
GIP and GLP-1 receptor agonist
$1,068.97 (111,041 RXs) $118.7 Mil
Eli Lilly -TRULICITY
GLP-1 receptor agonists
$977.96 (91,440 RXs) $89.4 Mil
2025-Alaska Medicaid Prescriptions
$ 201,963,946
Per RX Cost: $163.10
Total Number of Prescriptions: 1,238,297
Total Medicaid Amount Reimbursed: $201,963,946
Total Amount Reimbursed: $213,724,126
Total Non-Medicaid Amount Reimbursed:
$11,760,180
% of Non-Medicaid Reimbursed: 5.8
Some Top RX Costs
Novo Nordisk-OZEMPIC
GLP-1 receptor agonist
$923 (17015 RXs) $15.7 Million
AbbVie-HUMIRA
Antipsoriatics, immunosuppressant
$7,555 (1355RXs) $10.2 Million
Alexion Pharmaceuticals-STRENSIQ
Perinatal, infantile, and juvenile-onset hypophosphatasia
$63,298 (23 RXs) $1.4 Million
Highest Utilization ALBUTEROL
Bronchodilator for asthma and COPD
(33,763 RXs) $1.2 Million
Indivior Inc.-SUBLOCADE
Moderate-to-severe opioid use disorder
$2067 (3747 RXs) $7.7 Million
2025-Arkansas Medicaid Prescriptions
$499,622,377
Per RX Cost: $92.11
Total Number of Prescriptions: 5,424,363
Total Medicaid Amount Reimbursed: $499,622,377
Total Amount Reimbursed: $467,349,642
Total Non-Medicaid Amount Reimbursed:
$32,272,734
% of Non-Medicaid Reimbursed: 6.5
Some Top RX Costs
AbbVie-HUMIRA(CF)
Tumor necrosis factor blocker
$8,968.57 (2492 RXs) $22,3 Million
Takeda Pharmaceuticals-VYVANSE
CII-Central nervous system stimulant
$378 (48,970 RXs) $18.5 Million
Janssen Pharmaceuticals-INVEGA SUS
Atypical antipsychotic
$3,042 (4,394 RXs) $13.4 Million
2025-Colorado Medicaid Prescriptions $1,633,866,942.57
Per RX Cost: $168.95
Total Number of Prescriptions: 9,670,474
Total Medicaid Amount Reimbursed: $1,615,613,609
Total Amount Reimbursed: $1,633,866,942
Total Non-Medicaid Amount Reimbursed $18,253,333
% of Non-Medicaid Reimbursed: 1
Some Top Costs
Abbvie-HUMIRA
TNF blocker
$8,848.66 (9,040 RXs) $80 Mil
Eli Lilly -TRULICITY
GLP-1 receptor agonists
$1,090.74 (57,705 RXs) $63 Mil
Regeneron Pharmaceuticals-DUPIXENT
IL-4 receptor alpha antagonist
$3336.89 (15,853 RXs) $53 Mil
2025-DC Medicaid Prescriptions $305,302,169
Per RX Cost: $186.57
Total Number of Prescriptions:1,636,428
Total Medicaid Amount Reimbursed: $262,668,212
Total Amount Reimbursed: $305,302,169
Total Non-Medicaid Amount Reimbursed: $42,633,956
% of Non-Medicaid Reimbursed: 14
Some Top Costs
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors (INSTIs)
$4,106.94 (17,885 RXs) $70.1 Million
ViiV Healthcare/Janssen Pharmaceutical-CABENUVA
HIV-1 INSTI and a NNRTI
$5,957.47 (2242 RXs) $13.4 Million
ViiV Healthcare-DOVATO
HIV-1 INSTI and a NRTI
$4,098.21 (1872 RXs) $7.7 Million
2024-Florida Medicaid Prescriptions $3,276,941,969
Per RX Cost:$155.45
Total Number of Prescriptions: 21,080,594
Total Medicaid Amount Reimbursed: $3,161,856,439
Total Amount Reimbursed: $3,276,941,969
Total Non-Medicaid Amount Reimbursed: $115,085,530
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
AbbVie-HUMIRA
Tumor Necrosis Factor (TNF) Blocker / Biologic Response Modifier
$8,902.72 (12,621 RXs) $112.4 Million
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors (INSTIs)
$4,297.77 (22,141 RXs) $95.2 Million
Regeneron Pharmaceuticals-DUPIXENT
interleukin-4 (IL-4) receptor alpha antagonist
$4,128.11 (21,423 RXs) $88.4 Million
2025-Georgia Medicaid Prescriptions
$1,311,492,041
Per RX Cost: $95.58
Total Number of Prescriptions:13,721,466
Total Medicaid Amount Reimbursed: $1,244,580,674
Total Amount Reimbursed: $1,311,492,041.65
Total Non-Medicaid Amount Reimbursed:
$66,911,366
% of Non-Medicaid Reimbursed: 5
Some Top RX Costs
Regeneron Pharmaceuticals-DUPIXENT
interleukin-4 (IL-4) receptor alpha antagonist
$4,106.11 (12,863 RXs) $52.8 Million
Gilead Sciences-BIKTARVY
Integrase strand transfer inhibitors (INSTIs)
$4,090.49 (10,793 RXs) $44.1 Million
Vertex Pharmaceuticals-TRIKAFTA
triple combination therapy
$27,553.63 (1,481 RXs) $40.8 Million
2025-Indiana Medicaid Prescriptions $2,825,030,928
Per RX Cost: $161.60
Total Number of Prescriptions: 17,481,426
Total Medicaid Amount Reimbursed:
$ 2,740,844,206
Total Amount Reimbursed: $ 2,825,030,928
Total Non-Medicaid Amount Reimbursed:
$ 84,186,722
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
AbbVie-VRAYLAR
atypical antipsychotic
$1,721.95 (46,748 RXs) $80.5 Million
AbbVie-HUMIRA(CF)
TNF Blocker
$8,899.92 (8,446 RXs) $75.2 Million
Vertex Pharmaceuticals-Trikafta
triple-combination therapy
$26,936.80 (2,622 RXs) $70.6 Million
2025-Kansas Medicaid Prescriptions $353,156,399
Per RX Cost: $120.70
Total Number of Prescriptions: 2,925,946
Total Medicaid Amount Reimbursed: $315,943,756
Total Amount Reimbursed: $353,156,399
Total Non-Medicaid Amount Reimbursed:
$37,212,642
% of Non-Medicaid Reimbursed: 11
Some Top RX Costs
Eli Lilly -ZEPBOUND
dual agonist targeting GIP and GLP-1 receptors $1,049.07 (24,215 RXs) $25.4 Million
AbbVie-VRAYLAR
atypical antipsychotic
$1,371.81 (8,362 RXs) $11.5 Million
Janssen Pharmaceuticals -INVEGA
atypical antipsychotic
$3,020.19 (3,602 RXs) $10.9 Million
2025-Louisana Medicaid Prescriptions $2,385,095,329
Per RX Cost: $138.43
Total Number of Prescriptions: 17,230,165
Total Medicaid Amount Reimbursed: $ $2,285,316,029
Total Amount Reimbursed: $ 2,385,095,329
Total Non-Medicaid Amount Reimbursed: $ $99,779,299
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Eli Lilly -MOUNJARO
dual GIP and GLP-1 receptor agonist
$1,044.99 (99,936 RXs) $104.4 Million
AbbVie-HUMIRA(CF)
TNF Blocker
$9,573.56 (10,476 RXs) $100.3 Million
Gilead Sciences-BIKTARVY
Antiviral combination integrase strand transfer inhibitors (INSTIs)
$4,124.31 (23,142 RXs) $95.4 Million
2025-Maryland Medicaid Prescriptions $1,719,764,113
Per RX Cost: $116.93
Total Number of Prescriptions: 14,707,975
Total Medicaid Amount Reimbursed:
$1,695,991,709
Total Amount Reimbursed: $1,719,764,113
Total Non-Medicaid AmountReimbursed: $23,772,403
% of Non-Medicaid Reimbursed: 1
Some Top RX Costs
Gilead Sciences-BIKTARVY
integrase strand transfer inhibitors (INSTIs)
$4,117.00 (30,680 RXs) $97.4 Million
Novo Nordisk -OZEMPIC
glucagon-like peptide-1 (GLP-1) receptor agonist $961.00 (101,340 RXs) $91.7 Million
Indivior Inc.-SUBOXONE
Partial Opioid Agonist/Opioid Antagonist combination
$299.00 (23,4379 RXs) $29.8 Million
2025-Michigan Medicaid Prescriptions
$ 4,166,680,649
Per RX Cost: $148.47
Total Number of Prescriptions: 28,063,876
Total Medicaid Amount Reimbursed: $4,033,046,976
Total Amount Reimbursed: $ 41,66,680,649
Total Non-Medicaid Amount Reimbursed: $133,633,673
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Novo Nordisk-WEGOVY
GLP-1 receptor agonist
$1291.69 (194,698) $251.5 Million
Eli Lilly-ZEPBOUND
GIP and GLP-1
$1,038.21 (161,470 RXs) $167.6 Million
AbbVie-HUMIRA
TNF blocker
$9,024.52 (16,568 RXs) $149.5 Million
2025-Mississippi Medicaid Prescriptions
$578,448,553
Per RX Cost: $117.68
Total Number of Prescriptions: 4,915,392
Total Medicaid Amount Reimbursed: $562,249,144
Total Amount Reimbursed: $ 578,448,553
Total Non-Medicaid Amount Reimbursed:
$ 161,994,09
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Novo Nordis-WEGOVY
Glucagon-like peptide-1 (GLP-1) receptor agonist
$1,321.29 (31,200 RXs) $41.2 Mil
AbbVie-HUMIRA
TNF blocker
$9,567.75 (2,404 RXs) $23 Mil
Vertex Pharmaceuticals-TRIKAFTA
CFTR Modulator / CFTR Combination Treatment
$ 27,626.41 (823 RXs) $22.7
2025-Montana Medicaid Prescriptions
$345,141,881
Per RX Cost: $131.37
Total Number of Prescriptions: 2,627,296
Total Medicaid Amount Reimbursed: $335,108,921
Total Amount Reimbursed: $ 345,141,881
Total Non-Medicaid Amount Reimbursed: $10,032,959
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
AbbVie-HUMIRA
tumor necrosis factor
$8,255.71 (2,122 RXs) $17.5 Mil
Vertex Pharmaceuticals-TRIKAFTA
CFTR Modulator
$27,364.47 (518 RXs) $14.2 Mil
Indivior Inc-SUBOXONE
Partial Opioid Agonist-Antagonist Comb
$358.33 (25,954 RXs) $9.3 Mil
2025-Nevada Medicaid Prescriptions
$864,937,027
Per RX Cost: $128.13
Total Number of Prescriptions: 6,750,459
Total Medicaid Amount Reimbursed: $835,570,188
Total Amount Reimbursed: $ 864,937,027
Total Non-Medicaid Amount Reimbursed: $29,366,838
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Novo Nordisk-OZEMPIC
(GLP-1) receptor agonist
$1,132.26 (41,334 RXs) $46.8 Mil
Gilead Sciences-BIKTARVY
integrase strand transfer inhibitors (INSTIs)
$4,147.22 (9,300 RXs) $38.6 Mil
Sanofi and Regeneron-DUPIXENT
immunotherapy
$3,935.49 (5,236 RXs) $28.5 Mil
2025-New Jersey Medicaid Prescriptions $1,846,858,325
Per RX Cost: $101.37
Total Number of Prescriptions: 18,219,776
Total Medicaid Amount Reimbursed: $1,765,056,346
Total Amount Reimbursed: $ 1,846,858,325
Total Non-Medicaid Amount Reimbursed: $81801979
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Sanofi and Regeneron-DUPIXENT
immunotherapy
$3,965.96 (19,896 RXs) $79 Mil
Gilead Sciences-BIKTARVY
integrase strand transfer inhibitors (INSTIs)
$4,240.08 (18,380 RXs) $78 Mil
Janssen Pharmaceuticals-INVEGA
Atypical antipsychotic
$3,207.37 (13,215 RXs) $42.4 Mil
2025-New York Medicaid Prescriptions $12,586,182,418
Per RX Cost: $176.68
Total Number of Prescriptions: 71,236,922
Total Medicaid Amount Reimbursed: $12,080,595,195
Total Amount Reimbursed: $ 12,586,182,418
Total Non-Medicaid Amount Reimbursed: $ 505,587,222
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Gilead Sciences-BIKTARVY
Antiretroviral (ARV) / Antiviral
$4,587.93 (173,975 RXs) $798.2 Mil
Novo Nordisk-OZEMPIC
(GLP-1) receptor agonist
$1,175.54 46 (5,191 RXs) $547 Mil
Boehringer Ingelheim and Eli Lilly-JARDIANCE
SGLT2 Inhibitor
$997.67 (354,269 RXs) $353.4 Mil
2025-North Dakota Medicaid Prescriptions $104,908,338
Per RX Cost: $116.36
Total Number of Prescriptions: 901,620
Total Medicaid Amount Reimbursed: $102,301,672
Total Amount Reimbursed: $ 104,908,338
Total Non-Medicaid Amount Reimbursed: $ 2,606,667
% of Non-Medicaid Reimbursed: 2
Some Top RX Costs
Abbvie -HUMIRA
TNF blocker
$8,612.53 (1,155 RXs) $9.95 Mil
Gilead Sciences-SOFOSBUVIR
Antiviral Agent
$23,247.65 (201 RXs) $4.7 Mil
Boehringer Ingelheim and Eli Lilly-JARDIANCE
SGLT2 Inhibitor
$800.51 (4,884 RXs) $3.9 Mil
2025-Oklahoma Medicaid Prescriptions $1,032,435,359
Per RX Cost: $129.72
Total Number of Prescriptions: 7,959,072
Total Medicaid Amount Reimbursed: $985,991,271
Total Amount Reimbursed: $ 1,032,435,359
Total Non-Medicaid Amount Reimbursed: $46,444,087
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Abbvie-HUMIRA
TNF blocker
$8,499.46 (8,712 RXs) $74 Mil
Janssen Pharmaceuticals-INVEGA
Atypical Antipsychotic
$3,881.88 (15,636) $60.7 Mil
Eli Lilly-TRULICITY
GLP-1 receptor agonist
$ 1,018.79 (43,084) $43.9 Mil
2025-Pennsylvania Medicaid Prescriptions $4,956,795,404
Per RX Cost: $159.99
Total Number of Prescriptions: 30,982,732
Total Medicaid Amount Reimbursed:
$4,650,937,034
Total Amount Reimbursed: $4,956,795,404
Total Non-Medicaid Amount Reimbursed: $305,858,369
% of Non-Medicaid Reimbursed: 6
Some Top RX Costs
Eli Lilly -ZEPBOUND
Incretin Mimetics
$1,068.23 (188,049 RXs) $201 Mil
Gilead Sciences-BIKTARVY
antiretroviral HIV-1
$4,198.02 (38,073 RXs) $160 Mil
Abbvie -HUMIRA
TNF blockers
$9,154.06 (16,982 RXs) $155.5 Mil
2025-South Carolina Medicaid Prescriptions $950,623,592.40
Per RX Cost: $130.62
Total Number of Prescriptions: 7,277,712
Total Medicaid Amount Reimbursed: $752,654,217
Total Amount Reimbursed: $950,623,592
Total Non-Medicaid Amount Reimbursed
$197,969,374 % of Non-Medicaid Reimbursed: 21
Some Top RX Costs
Abbvie-HUMIRA
TNF blocker
$9,682.13 (3,559 RXs) $34.5 Mil
Novo Nordisk-OZEMPIC
GLP-1 receptor agonist
$952.53 (35,132 RXs) $33.5 Mil
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$4,104.10 (7,857 RXs) $32.2 Mil
2025-Tennessee Medicaid Prescriptions $1,564,628,732.31
Per RX Cost: $129.44
Total Number of Prescriptions: 12,087,316
Total Medicaid Amount Reimbursed: $1,540,904,582
Total Amount Reimbursed: $1,564,628,732
Total Non-Medicaid Amount Reimbursed $23,724,149
% of Non-Medicaid Reimbursed: 2
Some Top RX Costs
Abbvie -HUMIRA
(TNF) blocker
$9,531.12 (6,136 RXs) $58.5 Mil
Sanofi & Regeneron-DUPIXENT
IL-4R (alpha) antagonist
$3,913.52 (16,109 RXs) $63 Mil
AbbVie and Gedeon Richter-VRAYLAR
atypical antipsychotic
$1,427.55 (35,974 RXs) $51.1 Mil
2025-Utah Medicaid Prescriptions $501,849,707.14
Per RX Cost: $150.67
Total Number of Prescriptions: 3,330,845
Total Medicaid Amount Reimbursed: $452,749,064
Total Amount Reimbursed: $501,849,707
Total Non-Medicaid Amount Reimbursed $49,100,642
% of Non-Medicaid Reimbursed: 10
Some Top RX Costs
Janssen Pharmaceuticals-INVEGA
Atypical Antipsychotic
$3,483.05 (5,879 RXs) $20.5 Mil
AbbVie-VRAYLAR
atypical antipsychotic
$1,451.10 (10,445 RXs) $15.2 Mil
Vertex Pharmaeuticals-TRIKAFTA
CFTR combination treatment
$28,233.05 (435 RXs) $12.3 Mil
2025-Virginia Medicaid Prescriptions $2,568,691,266.23
Per RX Cost: $122.59
Total Number of Prescriptions: 20,953,472
Total Medicaid Amount Reimbursed: $2,453,946,779
Total Amount Reimbursed: $2,568,691,266
Total Non-Medicaid Amount Reimbursed $114,744,486
% of Non-Medicaid Reimbursed: 4
Some Top RX Costs
Eli Lilly -TRULICITY
GLP-1 receptor agonist
$979.59 (11,548 RXs) $113 Mil
AbbVie-HUMIRA
TNF Blocker
$8,851.21 (11,797 RXs) $104.4 Mil
Gilead-BIKTARVY
Integrase strand transfer inhibitors
$4,629.74 (17,061 RXs) $79 Mil
2025-West Virginia Medicaid Prescriptions $885,077,405.93
Per RX Cost: $120.99
Total Number of Prescriptions: 7,315,240
Total Medicaid Amount Reimbursed: $859,462,648
Total Amount Reimbursed: $885,077,405
Total Non-Medicaid Amount Reimbursed $25,614,757
% of Non-Medicaid Reimbursed: 3
Some Top RX Costs
Novo Nordisk-OZEMPIC
GLP-1 receptor agonist
$970.47 (17,015 RXs) $73.4 Mil
Abbvie-HUMIRA
TNF blocker
$9,291.82 (5,904 RXs) $55 Mil
Indivior Inc-SUBOXONE
Partial Opioid Agonist/Opioid Antagonist
$194.45 (266,278 RXs) $52 Mil
2025-Wyoming Medicaid Prescriptions $50,306,268,70
Per RX Cost: $128.34
Total Number of Prescriptions: 391,989
Total Medicaid Amount Reimbursed: $47,334,213
Total Amount Reimbursed: $50,306,268
Total Non-Medicaid Amount Reimbursed: $2,972,055
% of Non-Medicaid Reimbursed: 6
Some Top RX Costs
Abbvie -HUMIRA
Tumor necrosis factor (TNF) blocker
$8,710.05 (348 RXs) $3 Mil
Genentech-OCREVUS 30
CD20-directed cytolytic monoclonal antibody
$28,306.32 (107 RXs) $3 Mil
Vertex Pharmaeuticals-TRIKAFTA
CFTR combination treatment
$27,410.93 (90 Rxs) $2.5 Mil